CompletedPhase 2NCT01950780

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Columbia University
Principal Investigator
Julian Mackay-Wiggan, MD, MS, M.D
Columbia University
Intervention
Ruxolitinib(drug)
Enrollment
12 target
Eligibility
18-75 years · All sexes
Timeline
20132016

Study locations (1)

Collaborators

Bill and Melinda Gates Foundation · Locks of Love

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01950780 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials